Prevalence and predictors of high-intensity end-of-life care among adolescents and young adults with cancer in Ontario: a population-based study using the IMPACT cohort.

Authors

null

Hallie Coltin

Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada

Hallie Coltin , Adam Rapoport , Chenthila Nagamuthu , Nancy N. Baxter , Paul C. Nathan , Jason D. Pole , Franco Momoli , Sumit Gupta

Organizations

Division of Haematology/Oncology, The Hospital for Sick Children, Toronto, ON, Canada, Paediatric Advanced Care Team, The Hospital for Sick Children, Toronto, ON, Canada, ICES, Toronto, ON, Canada, St. Michael's Hospital, University of Toronto, Toronto, ON, Canada, Centre for Health Services Research, The University of Queensland, Woolloongabba, Australia, School of Epidemiology and Public Health, Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada

Research Funding

Other Government Agency
Canadian Institutes of Health Research (CIHR), Other Foundation, Other Government Agency

Background: End-of-life (EOL) care in adolescents and young adults (AYA) with cancer is poorly characterized, though this group may be at risk of elevated rates of high-intensity (HI) care and consequently, increased EOL suffering. Few population-based studies exist, and are limited by incomplete clinical information. AYA care patterns can vary by locus of care (LOC – pediatric v. adult), but LOC disparities in AYA EOL care are unstudied. Methods: We conducted a retrospective decedent population-based cohort study of all Ontario AYA diagnosed between 15-21 years of age with 6 prevalent primary cancers between 1992-2012, who died ≤5 years from diagnosis. Chart-abstracted clinical data were linked to health services data. The primary composite outcome (HI-EOL care) included any of: intravenous chemotherapy ≤14 days from death; > 1 emergency department visit ≤30 days from death; or > 1 hospitalization or intensive care unit (ICU) admission ≤30 days from death. Secondary outcomes included measures of the most invasive (MI) EOL care: mechanical ventilation ≤14 days from death, and death in the ICU. Factors associated with HI-EOL were examined. Results: Of 483 patients, 292 (60.5%) experienced HI-EOL care, 98 (20.3%) were mechanically ventilated ≤14 days from death, and 110 (22.8%) died in the ICU. Patients with hematological malignancies (v. solid tumors) were at greatest risk of HI-EOL care (OR, 2.3; 95CI, 1.5-3.5, p < 0.01), mechanical ventilation (OR, 5.4; 95CI, 3.0-9.7, p < 0.01), and death in an ICU (OR, 4.9; 95CI, 2.8-8.5, p < 0.01). AYA who died in a pediatric center were substantially more likely to experience MI-EOL measures compared to those dying in adult centers (mechanical ventilation, OR 3.2, 95CI 1.3-7.6, p = 0.01). Assessment of interactions showed LOC-based disparities widening over the study period (ICU death in pediatric v. adult centres: early period OR 0.9, 95CI 0.3-2.9, p = 0.91; late period OR 3.3, 95CI 1.2-9.2, p = 0.02; interaction term p = 0.04). AYA living in rural areas were also at higher risk of experiencing mechanical ventilation (OR, 2.0; 95CI, 1.0-3.8, p = 0.04) and death in ICU (OR, 2.1; 95CI, 1.1-4.0, p = 0.02). Conclusions: AYA with cancer experience high rates of HI-EOL care, with patients in pediatric centers and those living in rural areas at highest risk of MI-EOL care. Our study is the first to identify LOC-based disparities in AYA EOL care. Future studies should explore mechanisms underlying these disparities, including potential differences in palliative care services.

Canadian Institutes of Health Research (CIHR) Other Foundation Other Government Agency

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Pediatric Oncology

Track

Pediatric Oncology

Sub Track

Symptom Management/Supportive Care/Palliative Care

Citation

J Clin Oncol 38: 2020 (suppl; abstr 10559)

DOI

10.1200/JCO.2020.38.15_suppl.10559

Abstract #

10559

Poster Bd #

446

Abstract Disclosures

Similar Abstracts

First Author: Emily Pang

First Author: Ryan Thomas

First Author: Kimberly J. Johnson

Abstract

2023 ASCO Quality Care Symposium

Evaluation of the contribution of county characteristics to the rural mortality disparity in cancer.

First Author: Jeffrey Franks